-The Times of India In a bid to induce a fresh life into the ailing Health services delivery system in Uttar Pradesh, the World Bank has signed a $152 million deal with the Central and UP governments. The funds will be used to finance the government's efforts to improve the efficiency, quality, and accountability of Health services in the state. The project, called the Uttar Pradesh Health Systems Strengthening Project (UPHSSP) for...
More »SEARCH RESULT
Total Matching Records found : 9389
Plan panel bats for merger of AIDS control with NRHM by Kounteya Sinha
India's HIV control programme could soon get merged with the country's flagship National Rural Health Mission (NRHM), if the Planning Commission has its way. The Commission's steering committee on Health for the 12th five-year Plan has proposed "incorporating AIDS control, universal Healthcare and universal access to essential medicines" into NRHM. Planning Commission member in-charge of Health Syeda Hameed said, "It is a serious recommendation to incorporate NACO under an overall National Health...
More »How TB is silently killing India’s mothers by Satyavrat Chaturvedi
According to the WHO, TB is the third leading cause of death for women aged 15-44 worldwide. When did we last consider TB as one of India’s biggest Health problems? To refresh memories, here are a few forgotten facts about TB in India: one of the leading causes of death in India, TB kills one person every two minutes and 750 people every day. The direct and indirect annual costs of...
More »Losing direction-Jayati Ghosh
The Budget provides proof of the United Progressive Alliance government having forgotten the importance of its own “flagship schemes”. BUDGET 2012-13 provides conclusive proof that the United Progressive Alliance (UPA) government has lost its way. It has managed the remarkable feat of upsetting almost everyone and making no one happy. The Budget is highly regressive in both taxation and spending terms and will raise prices of essentials, so aam aurat and...
More »A Strike against Pharma MNCs
-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public Health and the wider availability of life saving medicines. The German pharmaceutical company Bayer holds the patent...
More »
